Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.
25 August 2018 (15:50 - 16:20)
Organised by:
About the speakers
University of Toronto, Toronto (Canada)
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
5 More presentations in this session
Professor N. Marx (Aachen, DE)
Professor D. McGuire (Dallas, US)
Doctor J. Udell (Toronto, CA)
Professor S. Verma (Toronto, CA)
Professor N. Sattar (Glasgow, GB)
Access the full session
The Event
ESC Congress 2018
25 August 2018
15:50 CET
You may be interested in
Congress Presentation
3 September 2019
Congress Session
